171 results on '"Quintana, Elsa"'
Search Results
2. Tumour-selective activity of RAS-GTP inhibition in pancreatic cancer
3. Concurrent inhibition of oncogenic and wild-type RAS-GTP for cancer therapy
4. Author Correction: Tumour-selective activity of RAS-GTP inhibition in pancreatic cancer
5. Shp1 Loss Enhances Macrophage Effector Function and Promotes Anti-Tumor Immunity
6. Abstract B022: TEAD inhibition overcomes YAP/TAZ-driven resistance to RAS(ON) inhibitors
7. Supplementary Table S8 from Translational and Therapeutic Evaluation of RAS-GTP Inhibition by RMC-6236 in RAS-Driven Cancers
8. Supplementary Figure S1-S6 from Translational and Therapeutic Evaluation of RAS-GTP Inhibition by RMC-6236 in RAS-Driven Cancers
9. Supplementary Method from Translational and Therapeutic Evaluation of RAS-GTP Inhibition by RMC-6236 in RAS-Driven Cancers
10. Data from Translational and Therapeutic Evaluation of RAS-GTP Inhibition by RMC-6236 in RAS-Driven Cancers
11. Combining RASG12C(ON) inhibitor with SHP2 inhibition sensitises immune excluded lung tumours to immune checkpoint blockade: a strategy for turning cold tumours hot
12. Tumor-selective effects of active RAS inhibition in pancreatic ductal adenocarcinoma
13. 214 The KRASG12D(ON) covalent tricomplex inhibitor RM-044 increases tumor antigen presentation and TCR repertoire diversity to promote anti-tumor immunity in a preclinical model of KRASG12Dmutant cancer
14. Abstract LB015: Bi-steric mTORC1-selective inhibitors activate 4EBP1, suppress MYC, restore anti-tumor immunity, and cooperate with immune checkpoint inhibition to elicit tumor regression
15. Abstract 526: RMC-9805, a first-in-class, mutant-selective, covalent and oral KRASG12D(ON) inhibitor that induces apoptosis and drives tumor regression in preclinical models of KRASG12D cancers
16. Abstract 3475: RMC-9805, a first-in-class, mutant-selective, covalent and orally bioavailable KRASG12D(ON) inhibitor, promotes cancer-associated neoantigen recognition and synergizes with immunotherapy in preclinical models
17. Merkel Cell Carcinoma Dependence on Bcl-2 Family Members for Survival
18. Abstract 3597: Direct targeting of KRASG12X mutant cancers with RMC-6236, a first-in-class, RAS-selective, orally bioavailable, tri-complex RASMULTI(ON) inhibitor
19. Progress in understanding melanoma propagation
20. Phenotypic Heterogeneity among Tumorigenic Melanoma Cells from Patients that Is Reversible and Not Hierarchically Organized
21. Erratum: Synergistic effects of ion transporter and MAP kinase pathway inhibitors in melanoma
22. Heterogeneity in Cancer: Cancer Stem Cells versus Clonal Evolution
23. Enteric glia are multipotent in culture but primarily form glia in the adult rodent gut
24. Efficient tumour formation by single human melanoma cells
25. Abstract LB050: Modulation of innate and adaptive immunity in blood and tumor of patients receiving the SHP2 inhibitor RMC-4630
26. Abstract 1273: Discovery of a potent, selective, and orally bioavailable SOS1 inhibitor, RMC-023, an in vivo tool compound that blocks RAS activation via disruption of the RAS-SOS1 interaction
27. Endotoxin stimulates fecal pellet output in rats through a neural mechanism
28. Endotoxin inhibits gastric emptying in rats via a capsaicin-sensitive afferent pathway
29. Downregulation of nNOS and synthesis of PGs associated with endotoxin-induced delay in gastric emptying
30. Cancer Stem Cells
31. List of Contributing Authors
32. Shp1 Loss Enhances Macrophage Effector Function and Promotes Anti-Tumor Immunity
33. Abstract 2837: Dual inhibition of SHP2 and CDK4/6 leads to immunological memory and immune-mediated anti-tumor activity in a mouse syngeneic model of breast cancer
34. Allosteric Inhibition of SHP2 Stimulates Antitumor Immunity by Transforming the Immunosuppressive Environment
35. Melanoma: Do We Need a Hatchet or a Scalpel?
36. Transcriptional up-regulation of nNOS in the dorsal vagal complex during low endotoxemia
37. Abstract 5019: Allosteric inhibition of SHP2 suppresses CSF1R signaling and selectively reduces viability of M2 tumor associated macrophages contributing to anti-tumor immunity
38. Abstract A103: Allosteric inhibition of SHP2 induces antitumor immunity in PD-1-sensitive tumors through modulation of both innate and adaptive mechanisms
39. Online Education for WIC Professionals
40. Synergistic effects of ion transporter and MAP kinase pathway inhibitors in melanoma
41. Abstract 2322: The Hippo signaling pathway mediates BMP inhibition of cancer stem cells
42. Abstract C9: Human melanoma metastasis in NSG mice correlates with clinical outcome in patients
43. Human Melanoma Metastasis in NSG Mice Correlates with Clinical Outcome in Patients
44. Orientaciones Didácticas y Guía de Recursos del Area de Música
45. Cuadernos para la coeducación 9. Música, Educación Plástica y Visual. Etapa Secundaria
46. Abstract PL03-02: Some cancers follow a stem cell model, while other cancers have common tumorigenic cells with little hierarchical organization
47. iNOS‐derived nitric oxide mediates the increase in TFF2 expression associated with gastric damage: role of HIF‐1
48. T1967 iNOs-Derived No Mediates TFF2 Expression in the Damaged Mucosa of Aspirin-Treated Rats
49. Synthesis of nitric oxide in post‐ganglionic myenteric neurons during endotoxemia: implications for gastric motor function
50. Confocal visualization of nitric oxide in the myenteric plexus of the gastric fundus obtained from endotoxin-treated rats
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.